4//SEC Filing
Dahan Michel 4
Accession 0001562180-21-002541
CIK 0001517022other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 8:33 PM ET
Size
5.0 KB
Accession
0001562180-21-002541
Insider Transaction Report
Form 4
Dahan Michel
SVP, Chief Business Officer
Transactions
- Sale
Common Stock
2021-04-01$3.40/sh−1,211$4,117→ 265,550 total
Footnotes (1)
- [F1]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021.
Documents
Issuer
Akebia Therapeutics, Inc.
CIK 0001517022
Entity typeother
Related Parties
1- filerCIK 0001669737
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 8:33 PM ET
- Size
- 5.0 KB